Trial intelligence / Profile preview

Lithium and Brain Activity in Bipolar Disorder

NCT00596622Phase 4Completed

Sponsor
Indiana University
Start
Aug 2007
Primary completion
Jan 2012
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 4, open-label trial of lithium in bipolar disorder (BD), sponsored by Indiana University. Primary endpoint: Hamilton Depression Rating Scale at 8 weeks. Started Aug 2007; status: completed.

02

Drugs

lithium
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00596622.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00596622.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call